Skip to main content
Equibles

CALDWELL SUTTER CAPITAL, INC.

Position in LPCN — Lipocine Inc.

CIK 702007 SAUSALITO, CA
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$1,205
-$2,558 QoQ
Shares Held
471
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 36 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CALDWELL SUTTER CAPITAL, INC. holds $550,133 across 24 Biotechnology names. LPCN ranks #14 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,000 $148,960
2 INSM
INSMED Inc
 727 $77,512
3 MDGL
Madrigal Pharmaceuticals, Inc.
 118 $63,360
4 ASND
Ascendis Pharma A/S
 218 $58,144
5 IDYA
IDEAYA Biosciences, Inc.
 1,554 $57,917
6 TVTX
Travere Therapeutics, Inc.
 693 $39,369
7 PCVX
Vaxcyte, Inc.
 432 $25,112
8
626 $23,424

All Filings in LPCN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,205 471
2026-03-31 $3,763 471
2025-12-31 $3,782 471
2025-09-30 $1,342 471
2025-06-30 $1,488 471
2025-03-31 $1,497 471
2024-12-31 $2,298 471
2024-09-30 $2,114 471
2024-06-30 $3,881 471
2024-03-31 $2,449 471
2023-12-31 $1,314 471
2023-09-30 $1,403 471
2023-06-30 $2,373 471
2023-03-31 $2,544 8,000